Volume 22, Number 5—May 2016
Research
Acute Human Inkoo and Chatanga Virus Infections, Finland
Niina Putkuri
, Anu Kantele, Lev Levanov, Ilkka Kivistö, Markus Brummer-Korvenkontio, Antti Vaheri, and Olli Vapalahti
, Anu Kantele, Lev Levanov, Ilkka Kivistö, Markus Brummer-Korvenkontio, Antti Vaheri, and Olli Vapalahti
Table 2
Age group and sex of patients whose serum samples were tested and number of samples that were IgM positive for INKV and CHATV infections in Finland, 2001–2013*
| Characteristic | Patients, no. (%) | INKV infection | CHATV infection |
|---|---|---|---|
| Age range | |||
| 0–9 | 670 (8.42) | 1 | 0 |
| 10–19 | 717 (9.01) | 2 | 0 |
| 20–29 | 905 (11.37) | 0 | 0 |
| 30–39 | 1062 (13.34) | 1 | 0 |
| 40–49 | 1180 (14.82) | 2 | 1 |
| 50–59 | 1377 (17.30) | 5 | 1 |
| 60–69 | 1093 (13.73) | 1 | 0 |
| >70 |
957 (12.02) |
0 |
1 |
| Sex | |||
| F | 3802 (47. 76) | 8 | 0 |
| M |
4159 (52.24) |
6 |
3 |
| *CHATV, Chatanga virus; INKV, Inkoo virus. | |||
Page created: April 13, 2016
Page updated: April 13, 2016
Page reviewed: April 13, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.